Geriatric Trauma Care Program for Living Alone Older Adults With Injuries
Launched by KAOHSIUNG MEDICAL UNIVERSITY · Mar 27, 2025
Trial Information
Current as of May 10, 2025
Recruiting
Keywords
ClinConnect Summary
The Geriatric Trauma Care Program (GTCP) is a clinical trial designed to help older adults who have suffered injuries to their limbs and live alone. The study aims to understand how this special care program affects pain levels, mobility, feelings of loneliness, depression, and overall quality of life over a three-month period. By participating, older adults can contribute to important research that may improve care for others in similar situations.
To join the trial, participants must be at least 65 years old, live alone, have experienced a limb injury, and have been independent before their injury. They should also be comfortable using a smartphone. However, individuals with very severe injuries, cognitive impairments, or certain psychiatric conditions are not eligible. If you or a loved one meets these criteria, participating in this study can offer the opportunity to receive support and be part of improving care for older adults facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. willing to join this study for three months
- • 2. with limb injuries
- • 3. living alone in a household
- • 4. aged 65 years old or older
- • 5. independent before a traumatic injury
- • 6. having a smartphone.
- Exclusion Criteria:
- • 1. with an ISS greater than 16 (severe injuries)
- • 2. having cognitive impairments
- • 3. diagnosed with psychiatric illness
About Kaohsiung Medical University
Kaohsiung Medical University (KMU) is a leading educational and research institution located in Kaohsiung, Taiwan, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, KMU focuses on enhancing medical knowledge and improving patient outcomes across various fields, including medicine, nursing, and public health. The university's commitment to rigorous scientific inquiry and collaboration with healthcare professionals positions it at the forefront of clinical research, contributing significantly to the advancement of evidence-based practices and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung, , Taiwan
Patients applied
Trial Officials
Bih-O Lee, PhD
Principal Investigator
College of Nursing, Kaohsiung Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported